Discover 1,881 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Georgia presents extensive opportunities for healthy volunteers looking to participate in paid studies and individuals with specific health conditions alike. Research hubs in major cities like Atlanta, Augusta, and Savannah are actively recruiting participants, providing access to emerging therapies and top-tier medical care.
Filter
1
Filter results
Results: 1,881
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers
for
Malignant Digestive System Neoplasm
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT03800693
Phase2, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Winchester MA, Burlington MA, White Plains NY, Nyack NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase3, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: St. John's, Rimouski, Boston MA, Levis, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
Freedom-1 Study for Chronic Knee Pain
for
Osteoarthritic Knee Pain
Location: Fort Lauderdale FL, Trinity FL, Jasper GA, Dayton OH,
Sponsor: Curonix LLC
Sex: All
Age: 18+
Code: NCT03877653
Recruiting
The Influence of the Otago Exercise Program on Executive Function Among People Living With Mild to Moderate Dementia
for
Dementia
Location: Augusta GA
Sponsor: Augusta University
Sex: All
Age: 55+
Code: NCT05488951
Recruiting
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
for
Schizophrenia
Location: Philadelphia PA, Wilmington NC, Cary NC, Miami FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07379827
Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
for
Psychotic Disorders, Alzheimer Disease
Location: Toms River NJ, Miami FL, Doral FL, Homestead FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 55+
Code: NCT06540833
Phase2, Recruiting
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 12 - 70+
Code: NCT03715933
Phase1, Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma